Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Australian Family Physician
|
November 5, 2003
Ongoing management of hepatitis C
Hugh Harley, David Shaw, Ian Steven
Journal of Gastroenterology and Hepatology
|
December 17, 2003
Hepatic hydropericardium
Ting Kin Cheung, William Tam, Dylan Bartholomeusz, et al.
International Journal of Nursing Studies
|
December 14, 2011
Help-seeking and coping with the psychosocial burden of chronic hepatitis C: a qualitative study of patient, hepatologist, and counsellor perspectives
Benjamin J Stewart, Antonina A Mikocka-Walus, Hugh Harley, et al.
Gastroenterology
|
November 16, 2005
Mannose-binding lectin and liver transplantation
Daniel L Worthley, Peter G Bardy, Peter Angus, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH
|
December 16, 2015
An Aggravated Trajectory of Depression and Anxiety Co-morbid with Hepatitis C: A Within-groups Study of 61 Australian Outpatients
Benjamin J R Stewart, Deborah Turnbull, Antonina A Mikocka-Walus, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
October 27, 2012
Anxiety and depression in Australian chronic hepatitis C outpatients: prevalence and predictors
Benjamin Stewart, Antonina Mikocka-Walus, Joanne Morgan, et al.
ANZ Journal of Surgery
|
February 14, 2008
Liver transplantation: a small-volume unit experience
Vincent B Nieuwenhuijs, John W Chen, Libby John, et al.
Journal of Gastroenterology and Hepatology
|
July 12, 2018
Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications
Sze Pheh Yeap, Hugh Harley, Richard Thompson, et al.
Journal of Gastroenterology and Hepatology
|
December 16, 2011
Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: a multicenter clinical experience
Dilip Ratnam, Anouk Dev, Tin Nguyen, et al.
The New England Journal of Medicine
|
July 13, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3
Mitchell L Shiffman, Fredy Suter, Bruce R Bacon, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Australian Family Physician
|
November 5, 2003
Ongoing management of hepatitis C
Hugh Harley, David Shaw, Ian Steven
Journal of Gastroenterology and Hepatology
|
December 17, 2003
Hepatic hydropericardium
Ting Kin Cheung, William Tam, Dylan Bartholomeusz, et al.
International Journal of Nursing Studies
|
December 14, 2011
Help-seeking and coping with the psychosocial burden of chronic hepatitis C: a qualitative study of patient, hepatologist, and counsellor perspectives
Benjamin J Stewart, Antonina A Mikocka-Walus, Hugh Harley, et al.
Gastroenterology
|
November 16, 2005
Mannose-binding lectin and liver transplantation
Daniel L Worthley, Peter G Bardy, Peter Angus, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH
|
December 16, 2015
An Aggravated Trajectory of Depression and Anxiety Co-morbid with Hepatitis C: A Within-groups Study of 61 Australian Outpatients
Benjamin J R Stewart, Deborah Turnbull, Antonina A Mikocka-Walus, et al.
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists
|
October 27, 2012
Anxiety and depression in Australian chronic hepatitis C outpatients: prevalence and predictors
Benjamin Stewart, Antonina Mikocka-Walus, Joanne Morgan, et al.
ANZ Journal of Surgery
|
February 14, 2008
Liver transplantation: a small-volume unit experience
Vincent B Nieuwenhuijs, John W Chen, Libby John, et al.
Journal of Gastroenterology and Hepatology
|
July 12, 2018
Biliary transporter gene mutations in severe intrahepatic cholestasis of pregnancy: Diagnostic and management implications
Sze Pheh Yeap, Hugh Harley, Richard Thompson, et al.
Journal of Gastroenterology and Hepatology
|
December 16, 2011
Efficacy and tolerability of pegylated interferon-α-2a in chronic hepatitis B: a multicenter clinical experience
Dilip Ratnam, Anouk Dev, Tin Nguyen, et al.
The New England Journal of Medicine
|
July 13, 2007
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3
Mitchell L Shiffman, Fredy Suter, Bruce R Bacon, et al.
Page
of 2